BOSTON—The use of breast-conserving surgery with radiation boosts in patients with multiple ipsilateral breast cancers has an acceptably low rate of local recurrence, according to a new study.
Findings from the American College of Surgeons Oncology Group (ACOSOG) Z11102 clinical trial demonstrate that this approach results in a five-year local recurrence rate of 3.2%, leading the authors to conclude that breast-conserving therapy is a reasonable